Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing

Breast Cancer Research and Treatment

Volumn 133, Issue 1, 2012, Pages 393-398

  De Leeneer, K ^a   Van Bockstal, M ^a   De Brouwer, S ^a   Swietek, N ^a   Schietecatte, P ^a   Sabbaghian, N ^b   Van Den Ende, J ^c   Willocx, S ^c   Storm, K ^c   Blaumeiser, B ^c   Van Asperen, C J ^d   Wijnen, J T ^d   Leunen, K ^e   Legius, E ^e   Michils, G ^e   Matthijs, G ^e   Blok, M J ^f   Gomez Garcia, E ^f   De Paepe, A ^a   Tischkowitz, M ^b,g   Poppe, B ^a   Claes, K ^a   more..

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b MCGILL UNIVERSITY   (Canada)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

BRCA1 2 negative; Germline mutations; Hereditary breast and ovarian cancer; RAD51C

Indexed keywords

GENOMIC DNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EXON; FEMALE; FOUNDER EFFECT; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; HIGH RESOLUTION MELTING ANALYSIS; HIGH RISK POPULATION; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MOLECULAR PATHOLOGY; MUTATION RATE; MUTATIONAL ANALYSIS; ONCOGENE; OVARY CANCER; PATIENT REFERRAL; PRIORITY JOURNAL; RAD51C GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; TUMOR SUPPRESSOR GENE;

DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HUMANS; MALE; MUTATION, MISSENSE; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84860345647     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-1998-4     Document Type: Article

References (21)

1. J Ferlay DM Parkin E Steliarova-Foucher 2010 Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 4 765 781 20116997 10.1016/j.ejca.2009.12.014 1:STN:280:DC%2BC3c7js1CktA%3D%3D
2. PJ O'Donovan DM Livingston 2010 BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair Carcinogenesis 31 6 961 967 20400477 10.1093/carcin/bgq069
3. A Ahlbom P Lichtenstein H Malmstrom M Feychting K Hemminki NL Pedersen 1997 Cancer in twins: genetic and nongenetic familial risk factors J Natl Cancer Inst 89 4 287 293 9048832 10.1093/jnci/89.4.287 1:STN:280:DyaK2s3gtFSjsQ%3D%3D (Pubitemid 27085890)
4. TM Mack AS Hamilton MF Press A Diep EB Rappaport 2002 Heritable breast cancer in twins Br J Cancer 87 3 294 300 12177798 10.1038/sj.bjc.6600429 1:CAS:528:DC%2BD38XmtVOntL8%3D
5. MR Stratton N Rahman 2008 The emerging landscape of breast cancer susceptibility Nat Genet 40 1 17 22 18163131 10.1038/ng.2007.53 1:CAS:528:DC%2BD1cXhtVyrsQ%3D%3D
6. NG Howlett T Taniguchi S Olson B Cox Q Waisfisz C De Die-Smulders N Persky M Grompe H Joenje G Pals, et al. 2002 Biallelic inactivation of BRCA2 in Fanconi anemia Science 297 5581 606 609 12065746 10.1126/science.1073834 1:CAS:528:DC%2BD38XlslWrs7k%3D (Pubitemid 34815345)
7. E Levy-Lahad 2010 Fanconi anemia and breast cancer susceptibility meet again Nat Genet 42 5 368 369 20428093 10.1038/ng0510-368 1:CAS:528: DC%2BC3cXlt1OlsL0%3D
8. F Vaz H Hanenberg B Schuster K Barker C Wiek V Erven K Neveling D Endt I Kesterton F Autore, et al. 2010 Mutation of the RAD51C gene in a Fanconi anemia-like disorder Nat Genet 42 5 406 409 20400963 10.1038/ng.570 1:CAS:528:DC%2BC3cXkvVCjt7k%3D
9. A Meindl H Hellebrand C Wiek V Erven B Wappenschmidt D Niederacher M Freund P Lichtner L Hartmann H Schaal, et al. 2010 Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene Nat Genet 42 5 410 414 20400964 10.1038/ng.569 1:CAS:528: DC%2BC3cXkvVCjtbo%3D
10. C Loveday C Turnbull E Ramsay D Hughes E Ruark JR Frankum G Bowden B Kalmyrzaev M Warren-Perry K Snape, et al. 2011 Germline mutations in RAD51D confer susceptibility to ovarian cancer Nat Genet 43 9 879 882 21822267 10.1038/ng.893 1:CAS:528:DC%2BC3MXpvVOlsbY%3D
11. A Romero P Perez-Segura A Tosar JA Garcia-Saenz E Diaz-Rubio T Caldes M de la Hoya 2011 A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families Breast Cancer Res Treat 129 3 939 946 21537932 10.1007/s10549-011-1543-x 1:CAS:528:DC%2BC3MXhtFGitbrO
12. Thompson ER, Boyle SE, Johnson J, Ryland GL, Sawyer S, Choong DY, Kconfab, Chenevix-Trench G, Trainer AH, Lindeman GJ et al. (2011) Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients. Human mutation 12(66):433-43
13. MR Akbari P Tonin WD Foulkes P Ghadirian M Tischkowitz SA Narod 2010 RAD51C germline mutations in breast and ovarian cancer patients Breast cancer research BCR 12 4 404 20723205 10.1186/bcr2619
14. Y Zheng J Zhang K Hope Q Niu D Huo OI Olopade 2010 Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer Breast Cancer Res Treat 124 3 857 861 20697805 10.1007/s10549-010-1095-5 1:CAS:528:DC%2BC3cXhtlyrsrnI
15. Z Pang L Yao J Zhang T Ouyang J Li T Wang Z Fan T Fan B Lin Y Xie 2011 RAD51C germline mutations in Chinese women with familial breast cancer Breast Cancer Res Treat 129 3 1019 1020 21597919 10.1007/s10549-011-1574-3
16. LM Pelttari T Heikkinen D Thompson A Kallioniemi J Schleutker K Holli C Blomqvist K Aittomaki R Butzow H Nevanlinna 2011 RAD51C is a susceptibility gene for ovarian cancer Hum Mol Genet 20 16 3278 3288 21616938 10.1093/hmg/ddr229 1:CAS:528:DC%2BC3MXpt1Ohu78%3D
17. V Silvestri P Rizzolo M Falchetti I Zanna G Masala D Palli L Ottini 2011 Mutation screening of RAD51C in male breast cancer patients Breast cancer research BCR 13 1 404 21392410
18. M Vuorela K Pylkas JM Hartikainen K Sundfeldt A Lindblom A von Wachenfeldt Wappling M Haanpaa U Puistola A Rosengren M Anttila, et al. 2011 Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility Breast Cancer Res Treat 130 3 1003 1010 21750962 10.1007/s10549-011-1677-x 1:CAS:528:DC%2BC3MXhsFWjtbrN
19. MW Wong C Nordfors D Mossman G Pecenpetelovska KA Avery-Kiejda B Talseth-Palmer NA Bowden RJ Scott 2011 BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer Breast Cancer Res Treat 127 3 853 859 21409391 10.1007/s10549-011-1443-0 1:CAS:528:DC%2BC3MXmtlyrsrc%3D
20. J Clague G Wilhoite A Adamson A Bailis JN Weitzel SL Neuhausen 2011 RAD51C germline mutations in breast and ovarian cancer cases from high-risk families PLoS ONE 6 9 e25632 21980511 10.1371/journal.pone.0025632 1:CAS:528:DC%2BC3MXhtlCjsLrO
21. T Walsh S Casadei MK Lee CC Pennil AS Nord AM Thornton W Roeb KJ Agnew SM Stray A Wickramanayake, et al. 2011 Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing Proc Nat Acad Sci USA 108 44 18032 18037 22006311 10.1073/pnas.1115052108 1:CAS:528:DC%2BC3MXhsVOktLbN